Tumores de Pele

Estudo randomizado | Desfechos de longo prazo com nivolumabe associado a ipilimumabe ou nivolumabe isolado vs. ipilimumabe em pacientes com melanoma avançado.

6 Dez, 2021 | 15:51h

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma – Journal of Clinical Oncology

Editorial: CheckMate-067: Raising the Bar for the Next Decade in Oncology – Journal of Clinical Oncology

Estudo original: #ESMO19 – Randomized Trial: Improved Overall Survival at 5 Years with Combined Immunotherapy for Advanced Melanoma

---

Diretriz sobre angiossarcomas cutâneos – Atualização 2021.

26 Nov, 2021 | 11:53h

S1-Guideline Cutaneous Angiosarcomas – Update 2021 – Journal of the German Society of Dermatology

---

Desfechos de longo prazo de pacientes com metástase cerebral ativa de melanoma tratados com a combinação nivolumabe e ipilimumabe.

16 Nov, 2021 | 12:17h

Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study – The Lancet Oncology (link para o resumo – $ para o texto completo)

Comentário: Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases – The University of Texas MD Anderson Cancer Center

Estudo original: Study: Combination Immunotherapy for Melanoma Brain Metastases

Conteúdo relacionado: #ESMO19 – Randomized Trial: Improved Overall Survival at 5 Years with Combined Immunotherapy for Advanced Melanoma

---

Estudo randomizado | Benefício de sobrevida global com tebentafuspe no melanoma uveal metastático.

1 Out, 2021 | 18:33h

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma – New England Journal of Medicine

 

Comentário no Twitter

Treatment with tebentafusp resulted in longer overall survival than the control therapy among previously untreated patients with metastatic uveal melanoma. https://t.co/HnSdWItKIp pic.twitter.com/qu4huRn3Mu

— NEJM (@NEJM) September 27, 2021

 

---

Ponto de vista | Biópsia de linfonodo sentinela no melanoma cutâneo – em que ponto estamos?

23 Ago, 2021 | 12:51h

Sentinel Lymph Node Biopsy in Cutaneous Melanoma—Where Do We Stand? – JAMA Dermatology (gratuito por tempo limitado)

---

Relatório dos EUA | Taxas de mortes estão caindo para muitos cânceres comuns, incluindo os de pulmão e o melanoma.

15 Jul, 2021 | 10:30h

Relatório: Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics – JNCI: Journal of the National Cancer Institute

Comunicado de imprensa: Annual Report to the Nation: Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate – National Cancer Institute

Comentários: Death rates are declining for many common cancers in the U.S., report finds – STAT E Annual report to the nation: Rapid decrease in lung cancer and melanoma deaths – American Cancer Society

---

Ponto de vista | Vigilância ativa como opção de tratamento para carcinoma basocelular de baixo risco.

15 Jun, 2021 | 11:11h

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma – JAMA Internal Medicine

---